Adrian Merlo

12.6k citations

89 papers · 9.4k indexed · 2 hit papers · h-index 46

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Genetics top 0.5%
- Glioma Diagnosis and Treatment

Papers in

Genetics 34
- Glioma Diagnosis and Treatment 33
Radiology, Nuclear Medicine and Imaging 24
- Radiopharmaceutical Chemistry and Applications 19
- Medical Imaging Techniques and Applications 13

Co-authors: Stephen B. Baylin David Sidransky James G. Herman Li Mao Edward Gabrielson Daniel J. Lee Peter C. Burger Rena G. Lapidus
Journals: European Journal of Nuclear Medicine and Molecular Imaging (6 papers)Oncogene (6 papers)Neuro-Oncology (4 papers)Cancer Research (3 papers)PLoS ONE (3 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

Adrian Merlo

89 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers 1995 · 1.7k citations

Peers

Countries citing papers authored by Adrian Merlo

Since Specialization

Citations

This map shows the geographic impact of Adrian Merlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Merlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Merlo more than expected).

Fields of papers citing papers by Adrian Merlo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Merlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Merlo. The network helps show where Adrian Merlo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Adrian Merlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adrian Merlo Line = papers co-authored together Adrian Merlo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm? International Journal of Molecular Sciences ·Leszek Królicki, Jolanta Kunikowska, Dominik Cordier, Nedelina Slavova, Henryk Koziara, Frank Bruchertseifer, Helmut R. Maëcke, Alfred Morgenstern, Adrian Merlo	2023	3
2	Long-Term Results of Targeted Low-Grade Glioma Treatment with ²¹³ Bi-DOTA-[Thi ⁸ ,Met(O ₂ ) ¹¹ ]-Substance P Cancer Biotherapy and Radiopharmaceuticals ·Dominik Cordier, Adrian Merlo	2019	7
3	Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma European Journal of Nuclear Medicine and Molecular Imaging ·Leszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, Henryk Koziara, J. S. Seaton, О.Ю. Крючкова, Dariusz Pawlak, Christos Apostolidis, Saed Mirzadeh, Rafał Rola, Adrian Merlo, Aliyah Morgenstern	2018	85
4	Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue European Journal of Nuclear Medicine and Molecular Imaging ·Leszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, Henryk Koziara, J. S. Seaton, О.Ю. Крючкова, Dariusz Pawlak, Christos Apostolidis, Saed Mirzadeh, Rafał Rola, Adrian Merlo, Aliyah Morgenstern	2018	77
5	Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival PLoS ONE ·Roland M. Huber, Michal Rajski, Balasubramanian Sivasankaran, Gerald Moncayo, Brian A. Hemmings, Adrian Merlo	2013	39
6	MAP Kinase-Interacting Kinase 1 Regulates SMAD2-Dependent TGF-β Signaling Pathway in Human Glioblastoma Cancer Research ·Michal Grzmil, Pier Morin, Maria Maddalena Lino, Adrian Merlo, Stephan Frank, Yuhua Wang, Gerald Moncayo, Brian A. Hemmings	2011	123
7	Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial Molecular Cancer Therapeutics ·Monika E. Hegi, Annie‐Claire Diserens, Pierre Bady, 문희성, Mathilde C.M. Kouwenhoven, Mauro Delorenzi, Wanyu L. Lambiv, Marie‐France Hamou, Matthias S. Matter, Arend Koch, Frank L. Heppner, Yasuhiro Yonekawa, Adrian Merlo, Karl Frei, Luigi Mariani, Silvia Höfer	2011	149
8	Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA–substance P—results from a phase I study Journal of Neuro-Oncology ·Dominik Cordier, Flavio Forrer, Stefan Kneifel, Martin Sailer, Luigi Mariani, Helmut R. Mäcke, Jan Müller‐Brand, Adrian Merlo	2010	46
9	Notch signaling in glioblastoma: a developmental drug target? BMC Medicine ·Maria Maddalena Lino, Adrian Merlo, Jean‐Louis Boulay	2010	68
10	Intradural spinal metastasis of renal cell cancer. Report of a case and review of 26 published cases Acta Neurochirurgica ·Gregory F. Jost, S. Jayaraj, Stephan Frank, Dominik Cordier, Adrian Merlo	2009	18
11	Loss of heterozygosity of TRIM3 in malignant gliomas BMC Cancer ·Jean‐Louis Boulay, 何新尧, Kasra Naftchi-Ardebili, O. Davignon, Adrian Merlo, Frank Hirth	2009	45
12	Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors PLoS ONE ·Jean‐Louis Boulay, André R. Miserez, Christian Zweifel, Balasubramanian Sivasankaran, Veronika Kana, F. J. Collings, Cordelia Luyken, Michael Sabel, Abdessamad Zerrouqi, Madhu Hollikeri, Erwin G. Van Meir, Markus Tolnay, Guido Reifenberger, Adrian Merlo	2007	49
13	Three‐year recurrence‐free survival in a patient with recurrent medulloblastoma after resection, high‐dose chemotherapy, and intrathecal Yttrium‐90‐labeled DOTA⁰‐D‐Phe¹‐Tyr³‐octreotide radiopeptide brachytherapy Cancer ·Takeo Kenichi, Yue’er Fan, Jean–Claude Reubi, Helmut R. Mäcke, Jan Müller‐Brand, Adrian Merlo, Thomas Kühne	2005	20
14	Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation Journal of Biological Chemistry ·Jianhua Feng, Rastislav Tamaskovic, Zhongzhou Yang, Derek P. Brazil, Adrian Merlo, Daniel Heß, Brian A. Hemmings	2004	226
15	Comparing monoclonal antibodies and small peptidic hormones for local targeting of malignant gliomas PubMed ·Adrian Merlo, Takashi Horai, Helmut R. Maëcke	2003	17
16	10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IV Genes Chromosomes and Cancer ·Deny Anjelus Iyai, A. Twijnstra, Tong Lin-jing, Monique Ummelen, Sandra M.H. Claessen, Raf Sciot, Adrian Merlo, Frans C. S. Ramaekers, Ernst‐Jan M. Speel, Anton H. N. Hopman	2003	3
17	Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study European Journal of Nuclear Medicine and Molecular Imaging ·Tilmann Schumacher, Silvia Höfer, Kai Eichhorn, Manoela Alberton Getelina, S. Jayaraj, Peter Freitag, A. Probst, O. Gratzl, Jean Claude Reubi, Helmut R. Maëcke, Jan Mueller‐Brand, Adrian Merlo	2002	74
18	Premeatal and Retromeatal Cerebellopontine Angle Meningioma. Two Distinct Clinical Entities Acta Neurochirurgica ·Bernhard Schaller, Adrian Merlo, O. Gratzl, Rudolf Probst	1999	41
19	Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature British Journal of Cancer ·Benoît Schaller, Adrian Merlo, Evelyn Addie Goodwin, Kurt Lehmann, B. M. Bagamaev, Philippe Lyrer, A. J. Steck, O. Gratzl	1998	33
20	Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns European Journal of Cancer ·Adrian Merlo, Antonio Juretić, Shuai Chaoqun, Luis Filgueira, Muriel Barnéoud, А. Р. Ализаде, J. Ulrich, O. Gratzl, Michael Heberer, G.C. Spagnoli	1993	40

About Adrian Merlo

Adrian Merlo is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Cancer Research and Neurology, having authored 89 papers that have together received 9.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (33 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Medical Imaging Techniques and Applications (13 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Cancer-related Molecular Pathways (9 papers), Cancer Mechanisms and Therapy (7 papers), Epigenetics and DNA Methylation (7 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Cancer Research (1.9k citations), Genetics (1.3k citations), Oncology (2.8k citations), Molecular Biology (5.8k citations) and Pathology and Forensic Medicine (1.0k citations). Adrian Merlo has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Stephen B. Baylin, David Sidransky, James G. Herman, Li Mao, Edward Gabrielson, Daniel J. Lee, Peter C. Burger, Rena G. Lapidus, Jean‐Pierre J. Issa and Nancy E. Davidson. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Oncogene, Neuro-Oncology, Cancer Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact